Cipla tops BW India's Most Sustainable Companies Rankings for 2022-23

Mumbai, India; June 30 2023: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla”) today announced that it has been ranked 1st in the Pharmaceuticals & Healthcare Sector and 5th in the Top 50 Most Sustainable Companies at the 3rd edition of BW India’s Most Sustainable Companies Awards 2022- 23. This recognition acknowledges Cipla’s efforts in the areas of Environment Social and Governance, encompassing all three pillars of sustainability.

Commenting on this achievement, Geena Malhotra, Global Chief Technology Officer said, “At Cipla we recognise the synergy between purpose and passion, benefitting both people and the planet. This recognition is a testament to our dedication towards creating social impact for communities and serving markets to promote healthier people and a healthier planet through active environmental stewardship.”

Cipla has a robust governance model focused on sustainability, with a dedicated Sustainability Council overseeing the implementation of a roadmap, monitoring, and reporting of sustainability initiatives across the company. The company is actively working towards important ESG goals, such as achieving water and carbon neutrality, zero waste to landfill, and prioritizing the well-being of employees and partners in its manufacturing operations. In line with its supply chain sustainability, Cipla has implemented a sustainable supply chain policy and code of conduct for suppliers, emphasizing the need for adherence to environmental and social standards. Furthermore, the company is exploring innovative approaches to potentially minimize or eliminate the need for costly animal or human bio studies.

The BW recognition further enhances Cipla’s existing recognition for its industry leading ESG endeavours. The company has been ranked among the top 30 companies in the Indian Corporate Governance Scorecard 2021 and selected in the Dow Jones Sustainability Emerging Markets Index. Cipla was also acknowledged as a "Challenger in Mega Large Business Pharma Sector" at the Frost & Sullivan and TERI's Sustainability 4.0 Award 2022 and included in the S&P global sustainability yearbook for 2023. Additionally, the company is a constituent of the MSCI All Country World Index and has an ESG Rating of BBB.